ENTITY

Insulet Corp (PODD US)

82
Analysis
Health CareUnited States
Insulet Corporation is a medical device company that develops, manufactures and markets an insulin infusion system for people with insulin-dependent diabetes.
more
Refresh
bullishInsulet Corp
24 May 2024 15:00

Insulet Corporation: Will Its Innovative Edge In The Insulin Pump Market Last? - Major Drivers

Insulet Corporation reported an excellent first quarter of 2024 that has exceeded expectations. The demand for Omnipod 5 continues to rise, the...

Logo
288 Views
Share
bullishInsulet Corp
04 Mar 2024 01:00

Insulet Corporation: Is Its Strategy Of Connecting With Healthcare Professionals For Penetration In Niche Markets Working? - Major Drivers

Insulet Corporation reported strong Q4 2023 results, marking its eighth straight year of 20-plus percent revenue growth. The company's automated...

Logo
229 Views
Share
bullishInsulet Corp
01 Jan 2024 09:00

Insulet Corporation: Revolutionizing Diabetes Care with Omnipod 5! - Major Drivers

Insulet Corporation managed to exceed analyst expectations in terms of revenue as well as earnings. During the quarter, their revenue surpassed...

Logo
371 Views
Share
bullishEoflow
17 Jul 2024 14:35

Eoflow: Financing Requirements, Changing Shareholding Structure, and the Next Steps

Eoflow's shares surged by 30% to 15,080 won today. Eoflow announced today that the U.S. District Court in Massachusetts had revoked the injunction...

Logo
831 Views
Share
bullishInsulet Corp
15 Sep 2023 14:00

Insulet Corporation: Launch of Omnipod 5 & Other Major Developments

Insulet Corporation exceeded analyst expectations in terms of revenue as well as earnings. The company's revenue for the second quarter surpassed...

Logo
403 Views
Share
x